Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Convincing results: Stopping the spread of cancer in the body

22.11.2004


A team of Danish researchers have discovered that by blocking a specific enzyme, it is possible to check the spread of cancer in the body. This finding may be the first step towards preventing deaths due to cancer spreading to other parts of the body. The discovery may also help reduce the amount of chemotherapy used.



The discovery, which was recently published in the prestigious International Journal of Cancer, was made by a research team from the Finsen Laboratory at Copenhagen University Hospital – Rigshospitalet and the Institute of Molecular Biology at the University of Copenhagen. “What is special about the enzyme – urokinase plasminogen activator (uPA) – is that the cancer needs the enzyme in order to spread throughout the body, but the body does not need the enzyme to function normally. This means that we should be able to block the enzyme and thereby check the spread of the cancer without causing the strong side effects for the patients that we see with other forms of therapy today,” says Morten Johnsen, Institute of Molecular Biology, University of Copenhagen.

“When women discover a lump in their breast, it can be removed. But if the cancer has spread to other parts of the body, such as the lungs, then it can become life-threatening. So we’ve come a long way towards being able to limit the spread of the cancer in the body,” says Kasper Almholt, PhD, Finsen Laboratory.


At K.A.S. Herlev Hospital, doctors are very pleased with the discovery. “The research looks very promising. If the clinical trials also show that it is possible to halt the spread of the tumour, then the research team has found the key to stopping the spread of cancer in the body, which is the cause of most of the deaths among cancer patients today. This is a huge advance in cancer research,” says Torben Skovsgaard, Chief Hospital Physician, Department of Oncology, K.A.S. Herlev Hospital.

Reducing the spread of breast cancer to 1/7

The research findings, which are based on experiments on genetically modified mice, show that the spread of breast cancer in mice that do not have the enzyme is reduced to 1/7. The findings also show that the mice do not suffer in any way from not having the enzyme, i.e. they do not experience any side effects.
The next step is to develop a medication that works on mice. Only then will testing the medication on humans be considered.

Hope for cancer patients

More than 33,000 men and women are diagnosed with cancer every year. With the discovery of this enzyme, the researchers hope to be able to develop in the course of a few years a medication that can prevent the spread of cancer and, thus, reduce the number of deaths among cancer patients.

Associate Prof. Morten Johnsen | alfa
Further information:
http://www.molbio.ku.dk

More articles from Health and Medicine:

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

nachricht Spread of deadly eye cancer halted in cells and animals
13.11.2018 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Putting food-safety detection in the hands of consumers

15.11.2018 | Information Technology

Insect Antibiotic Provides New Way to Eliminate Bacteria

15.11.2018 | Life Sciences

New findings help to better calculate the oceans’ contribution to climate regulation

15.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>